Cite
HARVARD Citation
Jendle, J. et al. (2016). Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon‐like peptide‐1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD‐4 substudy. Diabetes, obesity & metabolism. 18 (10), pp. 999-1005. [Online].